FRM
EPZM

Fox Run Management’s Epizyme, Inc EPZM Stock Holding History

Fox Run Management’s Portfolio EPZM Stock Details EPZM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-11,717
Closed -$145K – 683
2019
Q1 		$145K Buy
+11,717
New +$131K 0.08% 411
2018
Q3 		– Sell
-31,428
Closed -$426K – 890
2018
Q2 		$426K Buy
31,428
+10,337
+49% +$161K 0.14% 308
2018
Q1 		$374K Buy
21,091
+1,816
+9% +$30.7K 0.09% 421
2017
Q4 		$242K Buy
19,275
+7,575
+65% +$110K 0.07% 526
2017
Q3 		$223K Buy
+11,700
New +$179K 0.06% 580
2016
Q2 		– Sell
-14,900
Closed -$181K – 713
2016
Q1 		$181K Buy
+14,900
New +$151K 0.12% 351

Other funds holding EPZM

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return